TMCnet News

Endocrine Testing Market to 2025 - Market is poised to grow at a CAGR of around 8.8% over the next decade to reach approximately $15.5 billion - Research and Markets
[August 04, 2016]

Endocrine Testing Market to 2025 - Market is poised to grow at a CAGR of around 8.8% over the next decade to reach approximately $15.5 billion - Research and Markets


Research and Markets has announced the addition of the "Global Endocrine Testing Market Analysis & Trends - Industry Forecast to 2025" report to their offering.

The Global Endocrine Testing Market is poised to grow at a CAGR of around 8.8% over the next decade to reach approximately $15.5 billion by 2025.

This industry report analyzes the global markets for Endocrine Testing across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Key Topics Cvered:



1 Market Outline

2 Executive Summary


3 Market Overview

3.1 Current Trends

3.1.1 Demand for low price tests due to increasing health concerns

3.1.2 Increase in Endocrine Disorders

3.1.3 Recent Technological Developments of Endocrine Testing

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

4 Endocrine Testing Market, By Diagnostic Technology

4.1 Tandem mass spectrometry

4.2 Sensor technologies

4.3 Immunoassay Technologies

4.4 Clinical chemistry technologies

4.5 Monoclonal and polyclonal antibodies

5 Endocrine Testing Market, By Test

5.1 Progesterone Test

5.2 Cortisol Test

5.3 Estradiol (E2) Test

5.4 Thyroid Stimulating Hormone (TSH) Test

5.5 Luteinizing Hormone (LH) Test

5.6 Human Chorionic Gonadotropin (hCG) Test

5.7 Insulin Test

5.8 Dehydroepiandrosterone sulfate (DHEAS) Test

5.9 Follicle Stimulating Hormone (FSH) Test

5.10 Prolactin Test

5.11 Testosterone Test

6 Endocrine Testing Market, By End User

6.1 Ambulatory Care Centers

6.2 Physician Offices

6.3 Hospitals

6.4 Home Based Tests

6.5 Commercial Laboratories

7 Endocrine Testing Market, By Geography

8 Leading Companies

- AB Sciex Pte. Ltd.

- Abbott Laboratories

- Agilent Technologies (News - Alert)

- Allele Biotechnology

- Bio-Rad Laboratories, Inc.

- BioMerieux SA

- Biomedical Diagnostics

- DiaSorin S.p.A.

- F. Hoffmann-La Roche Ltd.

- Laboratory Corporation of America Holdings (LabCorp)

- Meridian Bioscience

- Ortho-Clinical Diagnostics

- Quest Diagnostics

- Roche Diagnostics

- Siemens Healthcare GmbH (Siemens AG (News - Alert))

- Sysmex Corporation

- Thermo Fisher Scientific, Inc.

- Tosoh Bioscience

For more information visit http://www.researchandmarkets.com/research/vdr3lt/global_endocrine


[ Back To TMCnet.com's Homepage ]